Like many other countries, Singapore faces evolving healthcare demands, driven by a rapidly ageing population and increased prevalence of chronic diseases. Precision Medicine (PM) is an innovative approach. Scientists and doctors consider the patient’s genetic background, lifestyle, and environmental factors to pre-empt the development of diseases and optimise treatments. The National Precision Medicine (NPM) programme is a whole-of-government approach to explore how PM should be best deployed in Singapore to drive research insights, clinical innovation, and economic growth. Through NPM, we hope to contribute to Singaporeans living healthier lives and its eventual impact across other Asian countries.
Industry: Health and BioMedical Sciences
With the ubiquitous presence of cameras (e.g. CCTV cameras, mobile phones, etc.), there has been an explosion of images and video data. While these visual data presents advantages and conveniences, they come with a cost: potential breach of privacy and confidentiality, particularly for information related to human poses and actions. In this event, Associate Professor Robby T. Tan will focus on the technical challenges and the possible solutions to predict human 3D poses from a monocular video.
Tour the hotspots of R&D in quantum technologies in Singapore with expert guides from some of the research organisations doing the work. This session will introduce highlights of local research in quantum computing, quantum communication and quantum sensing and review mechanisms for companies to get a headstart with these technologies - from bringing problems to researchers to solve to trialling devices.
Analysing human attributes such as emotions, gender and age in images and videos is very important for many applications. Many existing methods perform well by utilising information from human faces. However, face images raise serious privacy concerns as they reveal people’s identity.
Humanity has been operating out of balance with natural resources for far too long, placing economic growth ahead of environmental and social costs. Individuals, corporates and governments are starting to recognise that we need to act responsibly to support positive change. The UN’s 17 Sustainable Development Goals (SDGs) have given us a measurement framework to pivot towards a more balanced future, respectful of Environment, Society and Governance (ESG).
As countries develop their strategies in line with their commitments to the Paris Agreement, the financial world is moving more and more towards sustainable finance. Sustainable finance generally refers to the process of integrating ESG considerations when making investment decisions. In Singapore, the Monetary Authority of Singapore (MAS) is taking active steps to promote sustainable financing and recently announced the placement of US$2 billion of its funds with asset managers who are committed to deepening green finance activities out of Singapore. In Switzerland, Geneva is a global hub for innovative sustainability-focused organisations, e.g. Sustainable Finance Geneva, which aims to accelerate the growth of sustainable finance by engaging in dialogue with the world's leading financial centres.
Carbon credits and carbon markets have an important role to play in the battle against climate change. They enable companies to support decarbonization beyond their own carbon footprint and help finance projects for the removal of carbon dioxide from the atmosphere, which will be needed to neutralize residual emissions that will persist even under the most optimistic scenarios for decarbonization. Voluntary carbon markets are extremely dynamic in their evolution. However, these markets have numerous challenges to overcome, largely revolving around transparency and credibility.
How can carbon markets help in the transition towards a low-carbon economy? What are the main hurdles to the broader adoption of carbon markets around the globe? Join us with our speakers to understand how AI technologies and innovation can help improve transparency and build trust in global carbon markets for inclusive and diverse participation, particularly taking advantage of the power of capital markets to drive ESG for the planet.
In response to the COVID-19 as the most pressing healthcare challenge of our time, the global science and technology innovation ecosystem has been collaborating and accelerating radical solutions to the pandemic and better meet the future's healthcare needs.
In Singapore, Deep Tech innovations have played a critical role to help manage the pandemic, such as Biofourmis’ AI-powered remote monitoring platform to detect early deterioration in COVID-19 patients, and also the Digital Health Passport, the first blockchain-powered solution to issue secure, tamper-proof digital COVID-19 medical records at scale with 100,000+ records issued and 4,000,000+ verifications performed. Similarly, health innovations across India have been growing fast in response to the COVID-19 pandemic. According to the “India’s Healthtech Landscape In A Post-Covid-19 World Report 2020” by DataLabs, the size of the HealthTech market in India is likely to increase to US$21 billion by 2025 from US$5.2 billion in 2019.
In this Leaders’ Dialogue, our industry leaders from Singapore and India will be discussing the impact of Deep Tech innovations on the future of healthcare and how startups, hospitals and other stakeholders may collaborate to accelerate the process.
Norway has an already well-documented track record of quality clinical trials, with a specific strength in oncology, which is the branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
The Norwegian Ministry of Health has recently launched an ambitious strategic plan to further establish Norway as a country of excellence in this important field.
To reach this goal, Norway will offer one of the oldest and broadest collections of health registries in the world - health data, biobanks and a health analysis platform offering a unique tool to pharmaceutical companies – to create a single entry point to access all the country’s clinical trial resources. This will be in combination with a well-structured specialist care system and a population with a high willingness to partake in clinical trials.
Join us in our presentations by experts in the Norwegian Healthcare system, who will share about such clinical trial strategies of the future. From this session, we hope for Singapore HealthTech players to develop a better understanding of the innovation needs and strategies from Norway, as well as hear about the clinical studies directly from the experts themselves. This could be relevant for clinical and open collaborations for researchers and overseas markets.
Citizens, the government and industry are on a daily basis assisted by artificial intelligence. With the accelerated adoption and continuous development, we need to be aware of the risks and protect but not block development. But what does it entail and how do we ensure ethics and responsibility are incorporated in algorithms? How can companies make that assessment in the development but also deployment of AI tools?
In the session AI and Ethics: The Key to a Successful Human-AI Relation, thought leaders and industry experts from Singapore and the Netherlands will share their vision in this domain. While small in size, Singapore and the Netherlands have created a lot of positive impact in the global AI domain. We will touch upon the role of ethics in AI development and deployment, how to assess whether AI tools are hitting the mark and what the most common pitfalls are.
Compared to most science fiction writers, Polish Stanislaw Lem’s thinking was both disinterested and far-reaching. In his works like the nonfictional ‘Summa Technologiae’, he explored the possibilities of artificial intelligence, virtual reality, and genetic engineering, comparing technological advancement to biological evolution. In this session, we will start with a keynote referring to some practical examples to address how Lem's literary concepts still spark interest in new technologies across contemporary Polish society and innovative and tech communities in Poland, and how relevant they are nowadays for such countries as Singapore. Dr Maciej Kawecki, President, Stanislaw Lem Institute will also compare perception of technology development and impact of key emerging technologies between the two nations.
Thereafter, we will also focus on technology perception and how both nations see the development and impact of emerging technologies. For instance, the speakers will discuss topics such as the similarities and differences in how AI and AI ethics are perceived in Poland and Singapore, how both countries see the development of robotics, nanotechnology and other key technologies. This session bridges the existing cooperation and projects and explores how we can build deeper technology bridge between Poland and Singapore in the coming years.
Agriculture and the worldwide food system are challenged to feed an estimated global population of 9.7 billion people by 2050 while simultaneously facing diminished land & water resources and increased threats from climate change. Meanwhile, the advancement of digital technologies in agriculture is progressing rapidly in both developed and developing economies.